We are live on
!
Find out more
GTCM
Gyon Technologies Capital Management Portfolio holdings
AUM
$267M
1-Year Est. Return
11.62%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$65.9M
(+22%)
Cap. Flow
+$67.5M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.22M |
| 2 |
TJX Companies
TJX
|
+$4.48M |
| 3 |
AstraZeneca
AZN
|
+$4.01M |
| 4 |
Canadian National Railway
CNI
|
+$3.93M |
| 5 |
Deere & Co
DE
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.51M |
| 2 |
PayPal
PYPL
|
+$3.48M |
| 3 |
Acuity Brands
AYI
|
+$3.39M |
| 4 |
Pfizer
PFE
|
+$3.35M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.31% |
| 2 | Technology | 18.47% |
| 3 | Healthcare | 15.14% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Pembina Pipeline
PBA
$27.9B
| $242K | 0.07% |
+7,639
| New | +$241K |
|
327
Horace Mann Educators
HMN
$2.19B
| $241K | 0.06% |
6,048
-4,468
| -42% | -$177K |
|
328
Bruker
BRKR
$7.8B
| $240K | 0.06% |
3,072
-5,105
| -62% | -$424K |
|
|
FOCS
329
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $238K | 0.06% |
4,542
-27,210
| -86% | -$1.39M |
|
330
Omnicell
OMCL
$1.64B
| $236K | 0.06% |
1,587
+45
| +3% | +$6.89K |
|
331
SiriusXM
SIRI
$10.1B
| $236K | 0.06% |
+3,865
| New | +$243K |
|
|
XLRN
332
DELISTED
Acceleron Pharma
XLRN
| $234K | 0.06% |
1,358
-14,589
| -91% | -$1.91M |
|
|
SNV
333
DELISTED
Synovus
SNV
| $230K | 0.06% |
+5,250
| New | +$222K |
|
334
Watsco Inc
WSO
$13.2B
| $227K | 0.06% |
+858
| New | +$241K |
|
335
America's Car Mart
CRMT
$27.5M
| $225K | 0.06% |
+1,929
| New | +$266K |
|
336
CVS Health
CVS
$123B
| $225K | 0.06% |
2,653
-9,209
| -78% | -$771K |
|
|
LSXMA
337
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $225K | 0.06% |
+6,484
| New | +$227K |
|
|
ARGO
338
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $225K | 0.06% |
+4,300
| New | +$226K |
|
339
Moody's
MCO
$81.9B
| $224K | 0.06% |
632
-426
| -40% | -$161K |
|
340
NewMarket
NEU
$8.21B
| $222K | 0.06% |
655
-546
| -45% | -$179K |
|
341
Morningstar
MORN
$7.37B
| $218K | 0.06% |
+842
| New | +$221K |
|
|
ZNGA
342
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $217K | 0.06% |
28,832
-33,296
| -54% | -$303K |
|
343
Cable One
CABO
$252M
| $214K | 0.06% |
+118
| New | +$231K |
|
344
Sonoco
SON
$5.64B
| $212K | 0.06% |
+3,552
| New | +$227K |
|
345
Dover
DOV
$28.4B
| $211K | 0.06% |
1,354
-3,705
| -73% | -$614K |
|
|
MNR
346
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $211K | 0.06% |
+11,292
| New | +$214K |
|
347
NiSource
NI
$20.8B
| $210K | 0.06% |
8,659
-3,074
| -26% | -$76.6K |
|
348
Regal Rexnord
RRX
$11.9B
| $210K | 0.06% |
+1,398
| New | +$201K |
|
349
Western Alliance Bancorporation
WAL
$8.87B
| $210K | 0.06% |
+1,926
| New | +$187K |
|
|
FOLD
350
DELISTED
Amicus Therapeutics
FOLD
| $209K | 0.06% |
+21,933
| New | +$224K |
|
Similar funds
CDIA
ACMV
SCM
RW
A
CAN
JW
APP
Gyon Technologies Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Gyon Technologies Capital Management held 522 positions worth $371M, up 22% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Gyon Technologies Capital Management deployed $67.5M of net new capital in Q3 2021, opening 181 new positions and adding to 107 existing holdings. Its largest new stake was AstraZeneca: 34,466 shares worth $4.14M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $3.35M trimmed.
- Gyon Technologies Capital Management's largest Q3 2021 buy was AstraZeneca: 34,466 shares worth $4.14M.
- Gyon Technologies Capital Management added most to Microsoft in Q3 2021, an estimated $5.22M increase.
- Gyon Technologies Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.35M.
- Gyon Technologies Capital Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $3.51M.
- Gyon Technologies Capital Management's ten largest holdings make up 12% of its $371M portfolio in Q3 2021.
- Gyon Technologies Capital Management opened 181 new positions and closed 160 in Q3 2021.
- Gyon Technologies Capital Management's portfolio value rose 22% quarter-over-quarter to $371M.
Based on Gyon Technologies Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.